Mannitol Vs Hypertonic Saline in the Treatment of Increased Intracranial Pressure in Traumatic Brain Injury Patients

Title: Mannitol Vs Hypertonic Saline in the Treatment of Increased Intracranial Pressure in Traumatic Brain Injury Patients

Authors: Jagadeesh Babu. K, Ramakrishna

DOI: http://dx.doi.org/10.18535/jmscr/v4i8.12

Abstract

References

Corresponding Author

Abstract

Medical management of increased intracranial pressure should include sedation, drainage of cerebrospinal fluid, and osmotherapy with either mannitol or hypertonic saline. The aim of this study is to compare the effects of equimolar doses of 20% mannitol solution and of 7.45% hypertonic saline solution (HS) in elevated intracranial pressure of traumatic brain injury patients. This study was conducted at Mamatha medical college, it includes 20 patients divided into 2 groups; mannitol group (M), and Hypertonic saline(HS)group. A single equimolar infusion (255 mOsm dose) of either 231 ml of 20% mannitol (M)or 100 ml of 7.45% hypertonic saline (HS) administered for 20min. Intracranial pressure, arterial blood pressure, cerebral perfusion pressure,brain tissue oxygen tension, serum sodium and osmolality, and urine output were measured at T0,30,60,90,120 min. The two drugs were efficient in reducing ICP. At 60 mins after the start of theinfusion, ICP was reduced by 44% ±17% of baseline values (mean ± SD) in the mannitol group vs. 33% ±12% of baseline values in the HS group. The CPP was elevated significantly in mannitol group compared to base line values whereas slight elevation was seen in HS group. Significantly greater increase inurine output notice in mannitol than HS, although there was no difference in the vascular filling requirement between the two treatments. HS caused a significant elevation of serum sodium and chlorideat 120 mins after the start of the infusion. It was concluded that equimolar dose of both drugs were effective in treatment of elevated intracranial pressure.

Keywords-Mannitol, hypertonic saline, intracranial pressure, traumatic brain injury.

References

1. Signorini DF, Andrews PJ, Jones PA, et al: Predicting survival using simple clinical variables: A case study in traumatic brain injury. JNeurolNeurosurg Psychiatry 1999; 66:20-25

2. Signorini DF, Andrews PJ, Jones PA, et al: Adding insuit to injury: The prognostic valueof early secondary insults for survival aftertraumatic brain injury. J Neurol Neurosurg Psychiatry 1999; 66:26-31

3. Rosner MJ, Rosner SD, Johnson AH: Cérébral perfusion pressure: Management protocol and clinical results. J Neurosurg 1995; 83:949-962

4. Fortune JB, Feustel PJ, Graca L, et al:Effect of hyperventilation, mannitoi, and ventricul-ostomy drainage on cérébralblood flow after head injury. / Trauma1995; 39:1091-1097

5. Doyle JA, Davis DP, Hoyt DB: The use ofhypertonic saline in thé treatment of traumatic brain injury. J Trauma 2001; 50:367-383

6. Bhardwaj A; Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep 2007;7:513-21

7. HanyShawkat, Mei-Mei Westwood, and Andrew Mortimer ;Mannitol: a review of its clinical uses.ContinEducAnaesthCrit Care Pain (2012) 12 (2): 82-85.

8. White H, Cook D, VenkateshB;The use of hypertonic saline for treating intracranial h ypertension after traumatic brain injury. Anesth Analg2006;102: 1836-46

9. Wakai A, Roberts I, SchierhoutG,Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007:CD001049.Google Scholar

10. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al: Guidelines forthe management of severe traumatic braininjury. II. Hyperosmolar therapy. J Neurotrauma 2007; 24:S14–S20

11. Diringer MN, Zazulia AR: Osmotic therapy:Fact and fiction. Neurocrit Care 2004;1:219–233

12. Sorani MD, Morabito D, Rosethal G, et al. Characterizing the dose–response relations-hip between mannitol and intracranial pressure in traumatic brain injury using a high-frequency physiological data collection system. J Neurotrauma2008;25:291-8.

13. Diringer MN, Zazulia AR: Osmotic therapy: Fact and fiction. Neurocrit Care 2004;1:219–233

14. Oken DE: Renal and extrarenal considerations in high-dose mannitol therapy. Ren Fail 1994; 16:147–159

15. White H, Cook D, Venkatesh B: The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. AnesthAnalg 2006; 102:1836–1846.

16. Forsyth LL, Liu-DeRyke X, Parker D Jr, et al: Role of hypertonic saline for the management of intracranial hypertension afterstroke and traumatic brain injury. Pharmacotherapy 2008; 28:469–484

17. Harutjunyan L, Holz C, Rieger A, et al: Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% inhe treatment of increased intracranial pressure in neurosurgical patients—A randomized clinical trial [ISRCTN62699-180]. CritCare 2005; 9:R530–R540

18. Munar F, Ferrer AM, de Nadal M, et al: Cerebralhemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma 2000; 17:41–51

19. Horn P, Munch E, Vajkoczy P, et al: Hypertonic saline solution for control of elevated intracranial pressure in patients with exhaustedresponse to mannitol and barbiturates. Neurol Res 1999; 21:758–764

20. Kirkpatrick PJ, Smielewski P, Piechnik S, et al: Early effects of mannitol in patientswith head injuries assessed using bedside multimodality monitoring. Neurosurgery 1996; 39:714–720

21. Sakowitz OW, Stover JF, Sarrafzadeh AS, et al: Effects of mannitol bolus administrationon intracranial pressure, cerebral extracellularmetabolites, and tissue oxygenation in severely head-injured patients. J Trauma 2007; 62:292–298

22. Paczynski RP: Osmotherapy: Basic conceptsand controversies. Crit Care Clin 1997; 13:105–129

23. Gilles Francony, Bertrand Fauvage, Dominique Falcon, Charles Canet, Henri Dilou, Pierre Lavagne et al. Equimolar doses of mannitol and hypertonic saline in thetreatment of increased intracranial pressure. Crit CareMed 2008; 36(3):795-800

24. Battison C, Andrews PJ, Graham C, et al: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranialpressure after brain injury. Crit Care Med 2005; 33:196–202

Abstract

References

Corresponding Author

Call For Paper Volume 12 Issue 10 November 2024

JMSCR Menu

Impact Factor SJIF 2024: 7.892

Crossref - DOI

Editorial Policy

Frequency of Publication

Submission of Articles

Search